SMAD2 and familial pancreatic carcinoma: Another in vitro study in pancreatic cancer demonstrated that itraconazole inhibit viability, induce apoptosis and suppress invasion and migration by impaired transforming growth factor beta (TGF-β)/mothers against decapentaplegic homolog 2/3 (SMAD2/3) signalling [197].